| __timestamp | Bristol-Myers Squibb Company | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15879000000 | 214161000 |
| Thursday, January 1, 2015 | 16560000000 | 283703000 |
| Friday, January 1, 2016 | 19427000000 | 346620000 |
| Sunday, January 1, 2017 | 20776000000 | 507666000 |
| Monday, January 1, 2018 | 22561000000 | 599674000 |
| Tuesday, January 1, 2019 | 26145000000 | 1123000000 |
| Wednesday, January 1, 2020 | 42518000000 | 729000000 |
| Friday, January 1, 2021 | 46385000000 | 810000000 |
| Saturday, January 1, 2022 | 46159000000 | 587000000 |
| Sunday, January 1, 2023 | 45006000000 | 787647000 |
| Monday, January 1, 2024 | 48300000000 |
Unleashing insights
In the competitive world of biopharmaceuticals, Bristol-Myers Squibb Company and Ionis Pharmaceuticals, Inc. have charted distinct paths over the past decade. From 2014 to 2023, Bristol-Myers Squibb's revenue surged by approximately 183%, peaking in 2021 with a remarkable $46 billion. This growth reflects their strategic acquisitions and successful drug launches. In contrast, Ionis Pharmaceuticals, a leader in RNA-targeted therapeutics, experienced a more modest revenue increase of around 268%, reaching its highest in 2019. Despite the smaller scale, Ionis's innovative approach has positioned it as a key player in the niche market of genetic medicine. This comparison highlights the diverse strategies and market dynamics within the pharmaceutical industry, offering insights into how different business models can lead to success.
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Exelixis, Inc.
Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Bristol-Myers Squibb Company vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Who Generates More Revenue? Regeneron Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Ionis Pharmaceuticals, Inc. vs Vericel Corporation